Expression of BD-2 is induced during inflammation in response to bacterial products and cytokines, and is initially expressed in a precursor form, which is cleaved to release the C-terminal active portion of the protein.

Suitable for use in FLISA and Western Blot. Other applications not tested.

FLISA: 0.5ug/ml Western Blot: 0.1-0.2ug/ml Optimal dilutions to be determined by the researcher.

Store product at 4°C in the dark. DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Caution: MaxLight™650 conjugates are sensitive to light. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

Note: Applications are based on unconjugated antibody.

Recombinant human Defensin beta 2.

Supplied as a liquid in PBS, pH 7.2. Labeled with MaxLight™650.

Purified by immunoaffinity chromatography.

Recognizes human Defensin beta-2.